The International Working Group for Antibody Validation, which we have mentioned before here on our blog, has just published its findings. This is especially apt as we embark on a week of antibody validation, with the 2nd International Antibody Validation Event taking place here in Bath on Thursday and Friday. We have had a good […]
Here at CiteAb we are always very interested in scientific publishing, and we recently had a discussion with Katherine Brown, executive editor at Development, about the journal’s fascinating past and what its future might hold. Development is published by ‘The Company of Biologists’, a not-for-profit charitable organization run by biologists for the benefit of the […]
This week is Open Access Week 2015, and by the number of tweets using the hashtag #oaweek it looks like a lot of you have been getting involved. Back in 2013 our team here at CiteAb put together a whistle-stop tour of the open access movement. This year we thought we’d take a look at […]
As part of Veterinary Month here at CiteAb, we’ve been busy reviewing the veterinary research journals for the antibody reporting guidelines they provide to researchers. We used SCImago to establish which the highest ranked veterinary journals are, and have looked in detail at some of the leading publications; Vaccine (who run veterinary as well as human […]
In an exciting step to simplify the process of collaborating and writing new research, F1000 has today announced the launch of innovative new tool F1000Workspace. As you’ll be aware, here at CiteAb we aim to enhance the effectiveness of research and to ensure that researchers have the tools required to make good decisions about the […]
Here at CiteAb we’ve been following the open access movement and changes in open access publishing, so we were excited to see eLife introduce ‘eLife Labs’ earlier this month. eLife Labs aims to make progression in open access publishing evidence-based and crowd-sourced. eLife explained: “We aim to improve our services to researchers on an ongoing […]
An article published today in Nature calls for the large scale production of recombinant monoclonal antibodies, along with other recombinant affinity reagents including aptamers and affimers, for use in the research market. Andrew Bradbury and Andreas Pluckthun argue that this would lead to increased reproducibility and promote progress in biomedical research. Here at CiteAb we […]
Here at CiteAb we are always very interested in developments in scientific publishing, and our recent discussion with Shreeya Nanda, Deputy Editor for Biology and Medicine at BioMed Central, was full of food for thought on a wide range of publishing issues. Here we share with you a behind-the-scenes view of this renowned open access […]
Whats the problem? So you’ve found the antibodies you need for your experiments (hopefully using CiteAb!), they helped you get some great results and now you’re ready to write your paper. How do you report the antibodies you used, it should be easy right? Perhaps not! What is surprising is that less than half of […]
Update: We received the following response from PLoS regarding the paper. Yesterday we raved about this paper in Nature that was covered by the press internationally and was a fantastic example of really good antibody reporting. Unfortunately, today we have the flip side of the story. Another really good piece of research has received […]
CiteAb is the largest citation-ranked antibody search engine and database. It provides an impartial way to find and compare antibodies that work.
We use our database of antibody publications to produce unique antibody market data, income from this data allows us to remain free to list and impartial.
Publication metadata is provided by PubMed®, a database of the US National Library of Medicine.
PubMed® is a registered trademark of US National Library of Medicine.
Company registered in England #08530854. VAT #179706954.
In partnership with
© CiteAb 2012-2015. All Rights Reserved.